Streetbeat News

Earnings

EVLV

Evolv Technology has increased its FY23 revenue guidance from $60M-$65M to $70M-$75M, which is higher than the estimated $64.94M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:31 pm

CXDO

Crexendo (NASDAQ:CXDO) reported Q2 earnings of $0.04 per share, beating the analyst consensus estimate of $0.01 by 300%. This is a 100% increase from the same period last year. The company also reported quarterly sales of $12.67 million, beating the analyst consensus estimate of $11.83 million by 7.10%. This is a 43.23% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:30 pm

ARLO

Arlo Technologies reported Q2 earnings of $0.06 per share, beating the analyst consensus estimate of $0.04 by 50%. This is a 500% increase from the same period last year. The company also reported quarterly sales of $115.08 million, beating the analyst consensus estimate of $110.18 million by 4.44%, but this is a 3.28% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:30 pm

AEYE

AudioEye reported its Q2 financial results, which led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:30 pm

ICCC

ImmuCell (NASDAQ:ICCC) reported Q2 losses of $(0.18) per share, a 100% increase from $(0.09) per share YoY. Sales also decreased by 8.50% to $3.53 million from $3.86 million YoY.

Portfolio Pulse from bharat@benzinga.com

August 10, 2023 | 8:30 pm

UHG

United Homes Gr (NASDAQ:UHG) reported Q2 earnings of $4.27 per share and $122.09 million in sales.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:29 pm

IVVD

Invivyd's shares are trading higher following the release of their Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:29 pm

BRCC

BRC (NYSE:BRCC) reported Q2 adjusted EPS of $(0.05), beating the estimate of $(0.06) by 16.67%. However, the company's sales of $91.95M missed the estimate of $92.08M by 0.14%. This represents a 77.27% increase in EPS and a 38.55% increase in sales compared to the same period last year.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 8:29 pm

BURU

Nuburu (AMEX:BURU) reported Q2 losses of $(0.18) per share and sales of $1.10 million.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:29 pm

APTO

Aptose Biosciences reported Q2 losses of $2.27 per share, missing the analyst consensus estimate of $2.01 by 12.94%. This represents a 37.58% increase in losses compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 8:27 pm